Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Pioneering research in Microdosing GLP-1 The AgelessRx Applied Science Team is leading the first clinical trial focused on the healthspan-enhancing potential of Microdosing GLP-1 Ongoing observational study including long-term tracking of diverse health outcomes in over 1,000 patients using a growing real-world database of patient-reported data Clinical collaborations are currently in development to expand the scope and impact of this research How it works GLP-1s bind to GLP-1 receptors beyond the brain and gut, reaching the heart, kidneys, blood vessels, and immune cells Shown to support signaling to longevity-related pathways like AMPK and mTOR, affecting key Hallmarks of Aging like oxidative stress, inflammation, DNA repair, mitochondrial function, and autophagy At low doses, may subtly restore balance to hormone signaling, reduce inflammation (immune cells), improve cognitive function, and cardiometabolic health Effects may vary based on individual biology and with factors including inflammation, weight, lifestyle, metabolic health, and health history
The next scheduled catalyst is earnings: Hims plans to report Q4 and full-year 2025 results after the close on February 23, 2026, followed by a conference call
They should also provide certificates of analysis for each batch
do not take a double dose
Aids workout recovery and energy
IC 95%=0,58-0,95)
US$ 25.59
US$ 23.32
US$ 25.00
US$ 28.98
US$ 27.35
US$ 28.50
US$ 20.26
